Amgen to Acquire Horizon Therapeutics for US$28.3 B
By Lucy Haggerty
Pharma Deals Review: Vol 2022 Issue 12 (Table of Contents)
Published: 19 Dec-2022
DOI: 10.3833/pdr.v2022.i12.2754 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In an attempt to address its upcoming revenue gap, Amgen has agreed to acquire Horizon Therapeutics for US$116...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS